HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[The clinical features of the autoimmune hemolytic anemia with both warm and cold autoantibodies].

AbstractOBJECTIVE:
To study the clinical characteristics of autoimmune hemolytic anemia (AIHA) with both warm and cold autoantibodies.
METHODS:
Clinical and laboratory characteristics of 23 cases of AIHA with both warm and cold autoantibodies admitted to our hospital between January 1994 and April 2004 were analyzed retrospectively.
RESULTS:
In comparison with the AIHA patients with both warm and cold autoantibodies in the 1980s, the present patients showed the following features: The proportion of this kind AIHA in all AIHA patients increased from 17.6% to 22.1%. There were more females, more primary cases (73.9%), more mixed subtypes of autoantibodies and more of IgM (56.5%). The hemolysis was related with thermal amplitude of autoantibodies and quantity of complement. The response to cortisone and other immunosuppressive drugs was good. The relapse rate was 77.8% in a median follow-up time of 4 months.
CONCLUSIONS:
AIHA with both warm and cold autoantibodies is related with the type and thermal amplitude of the autoantibody and the activation of complement. It can be treated effectively with combined immunosuppressive therapy, but the relapse rate is high.
AuthorsLi-min Xing, Zong-hong Shao, Hong Liu, Jun Shi, Jie Bai, Hua-quan Wang, Mei-feng Tu, Juan Sun
JournalZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi (Zhonghua Xue Ye Xue Za Zhi) Vol. 27 Issue 1 Pg. 42-4 (Jan 2006) ISSN: 0253-2727 [Print] China
PMID16732941 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Autoantibodies
  • Immunoglobulin M
Topics
  • Adolescent
  • Adult
  • Aged
  • Anemia, Hemolytic, Autoimmune (drug therapy, immunology)
  • Autoantibodies (immunology)
  • Female
  • Follow-Up Studies
  • Humans
  • Immunoglobulin M (immunology)
  • Male
  • Middle Aged
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: